Zeke Capital Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | $420K | Sell |
9,073
-1
| -0% | -$46 | 0.03% | 270 |
|
2022
Q3 | $351K | Sell |
9,074
-123
| -1% | -$4.76K | 0.03% | 279 |
|
2022
Q2 | $343K | Sell |
9,197
-84
| -0.9% | -$3.13K | 0.02% | 290 |
|
2022
Q1 | $411K | Buy |
+9,281
| New | +$411K | 0.02% | 272 |
|
2020
Q1 | – | Sell |
-19,385
| Closed | -$877K | – | 275 |
|
2019
Q4 | $877K | Sell |
19,385
-395
| -2% | -$17.9K | 0.07% | 233 |
|
2019
Q3 | $805K | Buy |
19,780
+1,200
| +6% | +$48.8K | 0.07% | 246 |
|
2019
Q2 | $799K | Sell |
18,580
-2,231
| -11% | -$95.9K | 0.08% | 235 |
|
2019
Q1 | $799K | Sell |
20,811
-1,160
| -5% | -$44.5K | 0.07% | 234 |
|
2018
Q4 | $776K | Sell |
21,971
-4,670
| -18% | -$165K | 0.07% | 248 |
|
2018
Q3 | $1.03M | Hold |
26,641
| – | – | 0.08% | 243 |
|
2018
Q2 | $871K | Buy |
26,641
+599
| +2% | +$19.6K | 0.08% | 209 |
|
2018
Q1 | $711K | Buy |
26,042
+15,754
| +153% | +$430K | 0.07% | 267 |
|
2017
Q4 | $255K | Sell |
10,288
-18,634
| -64% | -$462K | 0.03% | 429 |
|
2017
Q3 | $844K | Buy |
28,922
+19,895
| +220% | +$581K | 0.12% | 138 |
|
2017
Q2 | $250K | Hold |
9,027
| – | – | 0.05% | 229 |
|
2017
Q1 | $225K | Buy |
+9,027
| New | +$225K | 0.05% | 230 |
|